This HTML5 document contains 182 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n9http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34522261
rdf:type
wikibase:Item
schema:description
artigo científico (publicado na 2002) articolo scientifico vitskapeleg artikkel 2002年の論文 scientific article სამეცნიერო სტატია научная статья article científic מאמר מדעי scienca artikolo vitenskapelig artikkel tieteellinen artikkeli wissenschaftlicher Artikel teaduslik artikkel bilimsel makale tudományos cikk 2002年论文 videnskabelig artikel (udgivet 2002) vědecký článek ശാസ്ത്രപ്രബന്ധം​ artículu científicu espublizáu en 2002 wetenschappelijk artikel 2002 թուականի Մարտին հրատարակուած գիտական յօդուած 2002年論文 naučni članak مقالة علمية 2002年論文 2002 թվականի մարտին հրատարակված գիտական հոդված 2002年论文 επιστημονικό άρθρο 2002 nî lūn-bûn 2002年論文 мақолаи илмӣ article scientifique (publié 2002) 2002年论文 سائنسی مضمون научни чланак artikull shkencor บทความทางวิทยาศาสตร์ bài báo khoa học vetenskaplig artikel научна статия artigo científico 2002年论文 article scientific مقالهٔ علمی 2002年論文 2002年论文 artículo científico publicado en 2002 научни чланак 2002년 논문 наукова стаття, опублікована в березні 2002 artigo científico (publicado na 2002) artykuł naukowy мақолаи илмӣ 2002年論文 articol științific ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2002年论文 vedecký článok artikulong pang-agham mokslinis straipsnis
p:P577
wds:Q34522261-5D3620FF-45A8-445F-865E-7D3977D14C78
wdt:P577
2002-03-01T00:00:00Z
p:P407
wds:Q34522261-22D7D312-7610-4E3A-B25C-E4B50E11CB15
wdt:P407
wd:Q1860
p:P2860
wds:Q34522261-778CB295-BDA4-4F83-953F-C265BB23A2DA wds:Q34522261-79986BD6-1908-442E-9BEE-C125B0E5E2CE wds:Q34522261-833A23E8-073A-4495-AA17-D8A63E43B707 wds:Q34522261-B485305B-D8EE-4F65-B5FA-DE2EB0D98FC6 wds:Q34522261-BB778BD1-824A-4827-963E-E3C082F97AB2 wds:Q34522261-847318D8-4FBA-438F-8B57-85029DF1EE8B wds:Q34522261-914CDAC4-DC75-44AA-8FA6-E51920B1093A wds:Q34522261-9F4A957F-55B2-424C-9C30-C56F50886D47 wds:Q34522261-CBE5AFD1-F4C6-484C-8255-923ED6D5986C wds:Q34522261-C2FA50F4-41B5-4C60-A8C5-9E0B15D9EE3D wds:Q34522261-F589CC5D-E6A5-41EE-8159-95EEF6755701 wds:Q34522261-FC481BE5-ADE1-45A6-8698-73B40D86D884 wds:Q34522261-E60EC8A6-7071-456F-88B5-DD28B987497B wds:Q34522261-F13E01BC-A9C2-4704-9D7D-B8E974667589 wds:Q34522261-075C04BB-7C3C-47F3-8212-F9CF8B142865 wds:Q34522261-095395A3-31CD-4556-B065-41CA6229B32A wds:Q34522261-02CD40FB-AB8D-4380-B557-F6C3FCF1013F wds:Q34522261-24DC92A8-98A6-436C-89E2-E31747B998AB wds:Q34522261-28454EFC-C390-4494-A230-1E322CDE86E1 wds:Q34522261-1509C41D-57D1-4856-9786-992073E10F2C wds:Q34522261-1F0F4A24-1D7F-42E7-A87E-03D93A20772E wds:Q34522261-4AE94D7C-1CAC-4802-8507-7641BCF40978 wds:Q34522261-4B5D23E8-5DC0-4ED8-8047-F919F5522F3C wds:Q34522261-391EAAA4-8949-4F5E-83B2-ED4730E80165 wds:Q34522261-3B8D1BD2-2173-444A-9077-F33C50478014
wdt:P2860
wd:Q29619542 wd:Q67281032 wd:Q72759885 wd:Q34500030 wd:Q33732969 wd:Q52461335 wd:Q34502430 wd:Q57222310 wd:Q50852298 wd:Q68323341 wd:Q73218242 wd:Q36681840 wd:Q32172784 wd:Q57219400 wd:Q34239811 wd:Q29615215 wd:Q33929187 wd:Q43753467 wd:Q74195896 wd:Q44707583 wd:Q72029341 wd:Q57221906 wd:Q41341778 wd:Q68053927 wd:Q34562725
p:P2093
wds:Q34522261-331BFD03-857F-4FCC-982F-F5BD7B9EEF04 wds:Q34522261-4050FD10-214E-4BFC-B8FF-77A1394F3DA7 wds:Q34522261-46E20F58-649B-45A4-A31F-3F94D216606A wds:Q34522261-00CACEAE-4D9C-4413-A1B6-FE36EC3618CB wds:Q34522261-14716E69-0A29-4F1A-AF5B-EF9442A8C606 wds:Q34522261-08D96CF1-7A57-416A-B337-5B3F21683360 wds:Q34522261-C194946D-6033-44B9-BA7E-ED5463350024 wds:Q34522261-EC7E3DB6-197F-4920-BACA-882497FAFD3A wds:Q34522261-E1431C2E-844A-4030-A1C0-234A65C85E95 wds:Q34522261-73E6E8F9-D465-4666-B8C0-3C3708D6C366
wdt:P2093
Krister Kristiansson Frej Fyhrquist LIFE Study Group Stevo Julius Lars H Lindholm Markku S Nieminen Gareth Beevers Per Omvik Hans Ibsen Hans Wedel
rdfs:label
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
skos:prefLabel
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study
schema:name
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study
p:P50
wds:Q34522261-C0A828CC-B200-4984-9B68-0673EE425E31 wds:Q34522261-CF6AFB5B-6E4A-4E5B-B76F-DAD145FFEA84 wds:Q34522261-AC75100A-0D02-49E4-B71F-5A6DA8CC42FC wds:Q34522261-68A4FA3F-D1C7-42CD-94B7-87EADB73DA2C wds:Q34522261-7D5CF8DD-4520-40A9-920D-2BBC472D575D wds:Q34522261-185F67C5-4E93-4C71-BFC8-B36F6E1657EB
wdt:P50
wd:Q47156424 wd:Q47156427 wd:Q30029225 wd:Q29840595 wd:Q45903512 wd:Q87223976
p:P1476
wds:Q34522261-56D8CF28-9EA3-4A0D-BEF9-C76E8874F1AA
wdt:P1476
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
p:P304
wds:Q34522261-240ADE1F-FA42-4A86-BC43-C5DA14DBF7FC
wdt:P304
995-1003
p:P31
wds:Q34522261-58D56387-C8C7-4163-BB64-8C6FB2E948D0
wdt:P31
wd:Q13442814
p:P921
wds:Q34522261-8D9068E9-F71C-4A09-AC7A-256A2FA421A4 wds:Q34522261-B2BA63EC-C15C-48F8-A2DE-3C2BD2A4F36F wds:Q34522261-D6FE14C1-3C58-4740-8276-169552A67D2C
wdt:P921
wd:Q95566669 wd:Q11068 wd:Q410074
p:P698
wds:Q34522261-754777AA-538C-403E-AA57-C2FBCC8AB11B
wdtn:P698
n12:11937178
wdt:P698
11937178
p:P1433
wds:Q34522261-0679C22F-A1B6-4C7E-BDBF-9B39242A7B31
wdt:P1433
wd:Q939416
p:P433
wds:Q34522261-C970C1A3-475A-4E62-B5D2-D8DFF50A312F
p:P478
wds:Q34522261-CE597ABD-9645-4D5B-837D-F6BDE734012C
wdt:P433
9311
wdt:P478
359
p:P356
wds:Q34522261-04122BE4-67A6-4409-BC25-D7ECFD2C6356
wdtn:P356
n9:S0140-6736(02)08089-3
wdt:P356
10.1016/S0140-6736(02)08089-3